Evidence map›Paper›PMID 32903875›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2020

Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection.

Vanessa Vera, Sebastien Gagne, Jonathan S Myers, Iqbal Ike K Ahmed

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Recent Advancements in Glaucoma Surgery-A Review.Bioengineering (Basel, Switzerland) · 2023
    Review
  15. Review
  16. Defining the role of ab externo Xen gel stent in glaucomatous eyes with prior failed surgical intervention.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  17. Article
  18. XEN45 Gel Stent Combined with Healaflow Injectable Viscoelastic Implant.Case reports in ophthalmological medicine · 2023
    Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Vanessa VeraDepartment of Ophthalmology, Unidad Oftalmologica de Caracas, Caracas, Venezuela.
Sebastien GagneDépartment d'ophthalmologie de, Université de Montréal, Montréal, Canada.
Jonathan S MyersGlaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA.
Iqbal Ike K AhmedDepartment of Ophthalmology, University of Toronto, Toronto, Canada.
Université de Montréal · CAUniversity of Toronto · CAWills Eye Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The XEN Gel Stent (Allergan Inc., an Abbvie company) is an implant that lowers intraocular pressure by creating a filtration pathway from the anterior chamber to the subconjunctival space, using the same pathway as trabeculectomy. While the primary method for implantation is via ab interno approach, it is also possible to implant the device ab externo. This technique paper details the surgical steps for closed conjunctival implantation of the Gel Stent and provides surgical pearls for enhancing outcomes.

Indexed as

ab externoab internofiltration surgeryglaucomatransconjunctival implantationXEN Gel Stent

Identifiers

PMID32903875
PMCPMC7445523
OpenAlexW3049005471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.